Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections

Burns

Volumn 43, Issue 7, 2017, Pages 1532-1543

  Chadha, Parul ^a   Katare, Om Prakash ^b   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Bacteriophage; Burns; Infection; Klebsiella pneumoniae; Liposomes

Indexed keywords

LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BACTERIOPHAGE; BURN INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISPERSITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SYNTHESIS; HOST RANGE; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LIPOSOMAL DELIVERY; LIPOSOME LOADED PHAGE COCKTAIL; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGE COCKTAIL; PHAGE THERAPY; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BAGG ALBINO MOUSE; BURN; COMPLICATION; KLEBSIELLA INFECTION; PROCEDURES; VIROLOGY; WOUND INFECTION;

ANIMALS; BACTERIAL LOAD; BACTERIOPHAGES; BURNS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOSOMES; MICE; MICE, INBRED BALB C; PHAGE THERAPY; WOUND INFECTION;

EID: 85019145875     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2017.03.029     Document Type: Article

References (38)

1. Perween, N., Prakash, S.K., Siddiqui, O., Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res 9 (2015), 14–16.
2. Nasser, S., Mabrouk, A., Maher, A., Colonization of burn wounds in Ain Shams University Burn Unit. Burns 29 (2003), 229–233.
3. Findlay, J., Hamouda, A., Dancer, S.J., Amyes, S.G., Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 18 (2012), 140–146.
4. Shasha, S.M., Sharon, N., Inbar, M., Bacteriophages as antibacterial agents. Harefuah 143 (2004), 121–125 166.
5. Chhibber, S., Kaur, S., Kumari, S., Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 57 (2008), 1508–1513.
6. Kumari, S., Harjai, K., Chhibber, S., Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J Microbiol Biotechnol 19 (2009), 622–628.
7. Chhibber, S., Kaur, T., Kaur, S., Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS One, 8, 2013, 56022.
8. Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int, 23, 2015, 752930.
9. Singla, S., Harjai, K., Katare, O.P., Chhibber, S., Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae induced lobar pneumonia. J Infect Dis, 2015, 10.1093/infdis/jiv029.
10. Hyman, P., Abedon, S.T., Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 70 (2010), 217–248.
11. Merril, C.R., Biswas, B., Carlton, R., Jensen, N.C., Creed, G.J., Zullo, S., et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 93 (1996), 3188–3192.
12. Westwater, C., Kasman, L.M., Schofield, D.A., Werner, P.A., Dolan, J.W., Schmidt, M.G., et al. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob Agents Chemother 47 (2003), 1301–1307.
13. Bull, J.J., Levin, R., DeRouin, T., Walker, N., Bloch, C.A., Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2 (2002), 35–44.
14. Johnston, M.J., Semple, S.C., Klimuk, S.K., Ansell, S., Maurer, N., Cullis, P.R., Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin. Biochim Biophys Acta 1768 (2007), 1121–1127.
15. Boone, D.R., Castenholz, R.W., Bergey's manual of systematic bacteriology. Second ed., 2001, Springer, New York.
16. Cerveny, K.E., Paola, A., Duckworth, D.H., Gulig, P.A., Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 70 (2002), 6251–6262.
17. Adams, M., Bacteriophages. 1959, Intersciences, New York.
18. Sambrook, J., Fritsch, E.F., Maniatis, T., Molecular cloning: a laboratory manual. Second ed., 1989, Cold Spring Habor laboratory Press, Cold Spring Harbor, New York.
19. Chang, H.C., Chen, C.R., Lin, J.W., Shen, G.H., Chang, K.M., Tseng, Y.H., et al. Isolation and characterization of novel giant Stenotrophomonas maltophilia phage FSMA5. Appl Environ Microbiol 71 (2005), 1387–1393.
20. Bhatia, A., Kumar, R., Katare, O.P., Tamoxifen-entrapped topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 7 (2004), 252–259.
21. Goodridge, L., Gallacci, A., Griffiths, M.W., Morphological, host range and genetic characterization of two coliphages. Appl Environ Microbiol 69 (2003), 5364–5371.
22. Gulati, M., Grover, M., Singh, M., Singh, S., Study of azathioprine encapsulation into liposomes. J Microencapsulation 15 (1998), 485–494.
23. Soothill, J.S., Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 37 (1992), 258–261.
24. Brans, T.A., Dutrieux, R.P., Hoekstra, M.J., Kreis, R.W., Du Pont, J.S., Histopathological evaluation of scalds and contact burns in the pig model. Burns, 20, 1994, 548.
25. Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11 (2010), 69–86.
26. Goodridge, L.D., Designing phage therapeutics. Curr Pharm Biotechnol 11 (2010), 15–27.
27. Drulis-Kawa, Z., Majkowska-Skrobek, G., Maciejewska, B., Delattre, A.S., Lavigne, R., Learning from bacteriophages—advantages and limitations of phage and phage encoded protein applications. Curr Protein Pept Sci 13 (2012), 699–722.
28. Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53 (2001), 283–318.
29. Senior, J., Is half-life of circulating liposomes determined by changes in their permeability?. FEBS Lett 145 (1982), 109–114.
30. Herben, V.M., ten Bokkel Huinink, W.W., Schot, M.E., Hudson, I., Beijnen, J.H., Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer. Anticancer Drugs 9 (1998), 411–418.
31. Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.W., Zarghami, N., Hanifehpour, Y., et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett, 8, 2013, 102.
32. Hemanthkumar, M., Spandana, V., Liposomal encapsulation technology a novel drug delivery system designed for ayurvedic drug preparation. IRJP 2 (2011), 4–4-7.
33. Omri, A., Beaulac, C., Bouhajib, M., Montplaisir, S., Sharkawi, M., Lagace, J., Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother 38 (1994), 1090–1095.
34. Sande, L., Sanchez, M., Montes, J., Wolf, A.J., Morgan, M.A., Omri, A., et al. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J Antimicrob Chemother 67 (2012), 2191–2194.
35. Colom, J., Cano-Sarabia, M., Otero, J., Cortés, P., Maspoch, D., Llagostera, M., Liposome-encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp. Appl Environ Microbiol 81 (2015), 4841–4849.
36. Zimecki, M., Artym, J., Kocięba, M., Weber-Dąbrowska, B., Borysowski, J., Górski, A., Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiol, 9, 2009, 169.
37. Basnet, P., Hussain, H., Tho, I., Skalko-Basnet, N., Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci 101 (2012), 598–609.
38. Kumari, S., Harjai, K., Chhibber, S., Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. J Infect Dev Countries 4 (2010), 367–377.